We have shown that various forms of oligonucleotides, chimeric RNA-DNA oligonucleotide (RDO) and singlestranded oligodeoxynucleotide (ODN), are capable of chromosomal gene alterations in mammalian cells. Using two ODNs we corrected an inactivating mutation in the tyrosinase gene and introduced an activating mutation into the c-kit gene in a single albino mouse melanocyte. Relying on a pigmentation change caused by tyrosinase gene correction, we determined the frequency of gene targeting events ranging from 2 Â 10 À4 to 1 Â 10 À3 , which is comparable to our previously published data using RDO. However, ODN showed more reproducible gene correction than RDO and produced pigmented cells among 60% of experiments, in comparison with 10% by RDO. DNA sequence analysis of the converted cells revealed that two out of eight individual pigmented clones harbored the mutated c-kit gene. Targeted modification of both genes resulted in the ability of the tyrosinase to convert tyrosine to melanin, and in the constitutive activation of the Kit receptor kinase. Thus, for the first time, we demonstrate the feasibility of simultaneous targeting of two genes in a single cell and show that a selection strategy to identify cells that have undergone a gene modification can enrich the targeted cells with the desired gene alteration.
Introduction
An introduction of sequence-specific modifications into mammalian genome is a challenging objective of nonviral gene therapy. To achieve this goal, several approaches including oligonucleotide-based strategies for targeted gene alteration have been developed. The potential of this strategy for application in gene therapy or genome research has hitherto been limited by a relatively low frequency of chromosomal gene alteration. In order to overcome this obstacle, we developed a selection strategy to identify cells that have undergone a gene modification by the use of two single-stranded oligodeoxynucleotides (ODNs), one targeting a gene of interest and the other targeting a defective selectable marker gene that manifests a phenotypic change upon gene alteration. For a selectable marker, we utilized a pigmentation change caused by correction of the inactivating single point mutation in the tyrosinase gene that is essential for the melanin biosynthesis. 1 Usage of natural pigmentation in gene conversion studies offers a distinct advantage over the other strategies: live cells can be monitored for pigmentation change, cloned and characterized by their genotype. Using such clonal analysis, we previously demonstrated the capability of chimeric RNA-DNA oligonucleotide (RDO) to correct the mutant mouse tyrosinase gene resulting in inheritable genotypic and phenotypic alterations in albino melanocytes. 1 In order to improve the likelihood of gene targeting events, we have tested several modifications of the targeting oligonucleotides, including various designs of RDOs 2 and short single-stranded oligonucleotides (ODN) for their abilities to correct a point mutation in the LacZ vector 3 that has been developed in our laboratory. We showed that relatively short ODNs (25-61 nucleotides) homologous to the target sequence, except a single mismatch to the targeted base, are capable of a sequencespecific episomal and chromosomal gene correction of a single base mutation in the LacZ gene. Moreover, we compared the gene correction abilities of the ODNs in the sense and antisense orientations and found that ODN in the antisense orientation was more active than the ODN in sense orientation in gene correction. 3 Using such short oligodeoxynucleotides, we extended the application of oligonucleotide-based strategy to simultaneous alterations of two genes in a single cell, the tyrosinase and c-kit gene, that are essential for pigmentation and development of melanocytes.
Tyrosinase, a key enzyme in melanin synthesis, is produced exclusively by melanocytes. [4] [5] [6] [7] [8] [9] [10] Melanocytes (Melan-C) derived from the albino mouse contain a homozygous point mutation (TGT-TCT) in the tyrosinase gene resulting in an amino acid sequence change from Cys to Ser (C85S) of the mature tyrosinase. 5 This single point mutation is responsible for complete inactivation of tyrosinase and absence of pigmentation. 6, 10 Correction of this point mutation resulted in the restoration of the tyrosinase enzymatic activity and pigmentation change. 1, 11 Another protein that is important for the development and normal function of the pigmentation system is the Kit receptor, which belongs to the PDGF family of the transmembrane receptor tyrosine kinases. Signal transduction from this receptor is essential for the formation of hair pigmentation unit in adults 12 and crucial in embryogenesis, influencing development of germ cells, hematopoietic cells and first and foremost, pigmentation system. 13,14 About 14 known missense mutations resulting in a loss of function of the Kit have been shown to be responsible for depigmentation associated with the mouse dominant spotting (W) and human piebaldism. [15] [16] [17] At the same time, two gainof-function mutations in the c-kit gene have been found and characterized in human mast leukemia cells. 18, 19 One of these mutations is the substitution of the Asp to Val (D816V) in the phosphotransferase domain of the human Kit receptor. The analogous mutation, the substitution of Asp to Tyr (D814Y), has also been identified in murine mastocytoma cell line. 20 This mutation was shown to be responsible for the constitutive activation of the Kit tyrosine kinase in a ligand-independent manner and, as a consequence, for transforming potentials of the mutant Kit in mast cells. 21 In contrast, such activating mutation in the c-kit has never been found in normal melanocytes or melanomas. 22, 23 Interestingly, some studies have shown that melanoma growth was actually inhibited by activation of the Kit receptor by its ligand. [24] [25] [26] Thus, targeted inactivation or activation of the Kit receptor could result in the development of potential therapeutics for various disorders associated with abnormal function of the receptor.
Here, for the first time, we report the simultaneous targeted alteration of two genes, tyrosinase and c-kit by utilizing two ODNs in albino melanocytes as a mammalian cell model. First, we corrected the point mutation in the tyrosinase gene and determined the frequency of gene alteration, which was comparable to the previously published data using RDO, 1 ranging from 2 Â 10 À4 to 1 Â 10
À3
. Next, we simultaneously introduced two ODNs to albino melanocytes to correct the albino tyrosinase and to mutate the c-kit gene. Using the clonal analysis of pigmented tyrosinase-corrected cells we confirmed the targeted alteration of both genes in a number of clones at the level of DNA sequence and protein enzymatic activity.
Results
Design of the single-stranded oligonucleotides to alter tyrosinase and c-kit genes
To correct the albino point mutation (TCT-TGT) (C85S) in mouse tyrosinase, we designed the Tyr N ODN, which contains 45 nucleotides (nt) complementary to the sequence of the tyrosinase-coding strand (antisense orientation) except a single mismatch C/C, which is the targeted base. Interaction between the mutant tyrosinase gene and Tyr N ODN should correct the mutant -C-nucleotide to the wild type -G-that should replace the TCT codon with the TGT codon ( Figure 1a) . As we have shown previously, this single base change led to the restoration of the tyrosinase enzymatic activity and pigmentation change. 1, 11 To introduce the activating mutation into the c-kit (GAC-TAC), causing an amino acid substitution of Asp to Tyr (D814Y), we designed the KDY ODN that is complementary to a stretch of 45 nt to the c-kit codingstrand except a single mismatch G/A (Figure 1b) . This gain-of-function mutation is expected to cause a distinct phenotypic manifestation: continuous activation of the Kit tyrosine kinase that could lead to the changes in melanocytes proliferation and/or migration. Thus, simultaneous alteration of the tyrosinase and c-kit genes in albino melanocytes should result in the appearance of pigmented melanocytes with constitutively activated Kit receptor tyrosine kinase.
Targeted correction of the albino tyrosinase gene
In all experiments oligonucleotides were delivered into albino mouse melanocytes (Melan-C) by Superfectt or DMRIE-Ct transfection reagents. The Cytofectint previously shown to be effective in transfection of melanocytes 1 has not been used in this study due to discontinuation of the product by the manufacturer. Delivery of oligonucleotides has been optimized by using the fluorescein-labeled ODN as described previously. 1 Superfectt showed a better transfection efficiency but a higher toxicity than DMRIE-Ct, which revealed no cytotoxicity in melanocytes (data not shown).
First, the Tyr N ODN designed to restore tyrosinase enzymatic activity has been delivered into Melan-C cells using either Superfectt or DMRIE-Ct (see Materials and methods). For transfection we have used 2-10 mg of ODN per 2x10 4 cells. Transfected melanocytes were kept in culture and monitored for a pigmentation change that appeared approximately 3-7 days after transfection. The frequency of gene correction was determined by counting the number of pigmented cells and ranged from 2 Â 10 À4 to 1 Â 10 À3 . The dose of oligonucleotides used (2-10mg) or the choice of liposome (Superfectt or DMRIE-Ct) did not make appreciable differences in the number of pigmented cells. No pigmentation change has ever been detected when cells were transfected with the control ODN (Figure 1 ), which contains no mismatch to the albino tyrosinase gene.
Correction of the albino mutation has also been confirmed by the PCR-based RFLP analysis and direct DNA sequencing. For this purpose, pigmented cells were subcloned several times by using cloning cylinders. 1 The genomic DNA was isolated and analyzed from several individual pigmented clones ( Figure 2 ). The 354 bp fragment flanking the mutation site in the tyrosinase gene has been amplified by PCR (see Materials and methods). The correction of the tyrosinase albino mutation destroys the restriction site for the DdeI endonuclease. Therefore, the digestion of the PCR product of the mutant tyrosinase results in 144, 102, 73 and 35 bp fragments, while the digestion of the wild type generates 179, 102 and 73 bp fragments. Thus, the 179 bp fragment is a distinct feature of the corrected tyrosinase while the 144 bp fragment is specific for the mutant (Figure 2a ). The RFLP analysis revealed the presence of both 179 and 144 fragments indicating a single-allele correction No other sequence alterations were found within a 400 bp region, which has been sequenced for each clone. Both genotype and phenotype of these clones were stable and maintained over 7 months in tissue culture. Moreover, these pigmented melanocytes survived the freezing and thawing process and maintained the pigmented phenotype. Collectively, the above results demonstrate the ability of ODN to correct a single point mutation in the endogenous gene, tyrosinase, permanently and in a sequence-specific manner.
Simultaneous alteration of the tyrosinase and c-kit genes
To alter two genes simultaneously in a single cell, the Melan-C cells have been transfected with two ODNs, one to correct the tyrosinase (Tyr N) and the other to Oligonucleotide-based dual gene targetting V Alexeev et al introduce the gain-of-function mutation into the c-kit (KDY) ( Figure 1 ). The same amount of both ODNs were mixed and transfected to Melan-C cells according to the procedure described in the Materials and methods. The number of pigmented cells detected several days after transfection was similar to that observed when albino melanocytes were treated with Tyr N alone. Individual pigmented cells from three independent experiments were subcloned 5-7 times to ensure isolation of a single pigmented clone. Eight independent clones were kept in culture and sustained pigmented phenotypes for more than 5 months. The PCR-based RFLP analysis (data not shown) and DNA sequencing (Figure 3b ) of the genomic DNA isolated from individual pigmented clones revealed the presence of both the mutant and the wild-type tyrosinase sequences, confirming a single-allele Oligonucleotide-based dual gene targetting V Alexeev et al correction of this gene in all clones. The same genomic DNA has also been used for the DNA sequence analysis of the c-kit gene (see Materials and methods). As it can be seen from Figure 3b , the analysis of the c-kit DNA sequence revealed the presence of the predefined, targeted mutation of this gene in two out of eight analyzed individual clones. Interestingly, clone 8 showed the presence of the -T-nucleotide only, indicating the conversion of both c-kit alleles. At the same time, we detected both wild-type and mutant codons (GAC and TAC) in clone 6, indicating a single allele conversion. In order to illustrate the end result of gene alteration, we verified the enzymatic activities of two proteins, tyrosinase and Kit receptor.
Tyrosinase activity. Pigmentation of the corrected melanocytes indicates the presence of active tyrosinase in these cells. To confirm its enzymatic activity, melanocytes were lysed and proteins were separated by a polyacrylamide gel electrophoresis (PAGE) in a nondenaturing condition and analyzed by the DOPA oxidation reaction (see Materials and methods). Active tyrosinase should oxidize L-DOPA (L-3,4-dihydroxyphenylalanine) to melanin, producing a 'pigmented' band in a gel. All eight analyzed clones showed the presence of active enzyme in cell lysates, while Melan-C did not (Figure 4a ).
Kit activity. To examine the consequence of the activating mutation introduced into the c-kit, we compared the activities of the Kit intrinsic tyrosine kinase in the absence or presence of the Kit ligand, stem cell factor (SCF), among pigmented melanocytes containing the normal or the mutant c-kit. After the serum starvation, melanocytes with the activating mutation in c-kit are still expected to possess the Kit receptor tyrosine kinase activity, while melanocytes with the normal c-kit are not. Several clones were serum-starved for 3 days and either treated or untreated with SCF. The Kit receptor was precipitated from the cell lysates by using ACK45 Oligonucleotide-based dual gene targetting V Alexeev et al antibodies and its phosphorylation status was analyzed by the Western blot using anti-phosphotyrosine antibodies. Melanocytes with the normal c-kit showed an autophosphorylation of the Kit receptor only in the presence of SCF. In contrast, the Kit receptor was autophosphorylated in a ligand-independent manner in two c-kit altered clones 6 and 8 ( Figure 4b ). The same amount of Kit receptor was detected in all clones (Figure 4c) . Thus, the mutation in c-kit did not change the expression level of the Kit receptor but affected its enzymatic activity. To verify this constitutive activation of the Kit receptor, the kinase activity was determined in similar experimental conditions by in vitro kinase assay (see Materials and methods). Both c-kit altered clones showed elevated levels of tyrosine kinase activity independent of SCF (Figure 4d, e) , while melanocytes with the normal c-kit showed lower Kit kinase activities even after activation of the receptor with SCF. A slight increase in the kinase activity detected in clone 6 after SCF treatment could be explained by the activation of the receptor that has been produced from the normal allele of the c-kit. Collectively, the above results demonstrate the feasibility of simultaneous alteration of two genes in a single cell.
Discussion
Gene repair by oligonucleotides is intended to produce targeted alterations in the genome of eukaryotic cells. This approach has a potential to correct a mutation while maintaining the genomic organization important for appropriate expression and regulation of genes. Our laboratory and others have shown that various forms of oligonucleotides, RNA-DNA oligonucleotide (RDO) and single-stranded oligodeoxynucleotide (ODN), are capable of chromosomal gene alterations in mammalian cells. 27 One of the major limitations of gene targeting is the low frequency of homologous recombination (10 À5 -10
À6
) in mammalian cells. This low rate was overcome by the incorporation of selectable markers in gene targeting vectors to enrich the rare successfully targeted cells. 28 Here, we sought to overcome the limitation in the use of ODN-based gene targeting, a low frequency, by developing a selection strategy for identifying cells that have undergone a gene modification. We hypothesized that cells harboring abilities to alter one gene may also be competent in altering other genes. If we can identify and select those cells, which have undergone gene alteration in one gene, then the same cells may have alteration in the second gene.
To test whether ODN can alter two genes simultaneously in a single cell, we have chosen albino melanocytes. We have previously shown that the correction of single point mutation in the tyrosinase gene by RDO caused an inheritable genetic and phenotypic change. 1 In addition to the correction of tyrosinase, we also sought to change the c-kit gene in the same cell. The Kit receptor plays an important role in melanocytes migration, proliferation and differentiation. Either a loss or a gain-of-function mutation could be introduced into the c-kit gene. The loss-of-function mutations affect the ability of the melanocytes precursors to migrate, survive and/or proliferate during embryonic development. 14 Also, an inhibition of the Kit receptor can diminish proliferation of melanocytes 29 and may change the tyrosinase gene regulation. 30 Because we attempted to alter the c-kit and to correct the tyrosinase simultaneously, we chose to introduce a gain-of-function mutation into the c-kit gene.
Alteration of both genes by two ODNs was confirmed by the clonal analysis of pigmented cells at the level of the DNA sequence and enzymatic activity of two proteins, an active tyrosinase and a ligand-independent activation of the Kit receptor. Only single-allele gene correction of tyrosinase was observed among all characterized pigmented clones. Previously, we also have not detected any double-allele correction of tyrosinase using the RDO. 1 Interestingly, we could not detect the mutant tyrosinase protein that could be transcribed from the one remaining mutant allele in these clones and suggested a degradation of the mutant protein during the posttranslational processing. Consistent single-allele corrections among at least 30 clones generated by RDO in our previous study 1 and ODN in the current study, however, raise the possibility that one of the tyrosinase alleles may be silent and may not be accessible for targeting by oligonucleotides. Further studies are needed to resolve these two possibilities. Clonal analysis of the converted pigmented melanocytes revealed that two out of eight individual clones harbored the mutated c-kit gene. One clone showed a single-allele change (equal mixtures of G and T nucleotide) while the other showed changes in both c-kit alleles (T nucleotide only). At this point, however, we cannot exclude the possibility that the presence of T nucleotide may be caused by a loss of one copy of chromosome 5 where c-kit gene is located and not by a double-allele correction. The chromosomal analysis of Melan-C cells indicated that 12 out of 50 cells were not diploid at passage 17. 31 Although we used Melan-C cells at relatively early passages (p18-p22), where the percentage of non-diploid cells is still low, it is possible that the cell from which clone 8 originated may have only one copy of chromosome 5. For the first time, we demonstrate the feasibility of simultaneous targeting of two genes in the same cell by clonal analysis.
In the present study, we compared the capability of RDO (our previous report) 1 and ODN (current study) to correct the tyrosinase gene in albino melanocytes. The frequency of gene conversion by RDO ranged from 1 Â 10 À5 to 1 Â 10
À1
, as determined by counting the number of pigmented cells. 1 Our mechanistic study indicates that the DNA-containing strand of RDO, which is similar to the ODN, is responsible for the gene repair activity and the RNA-containing strand could be responsible for the stabilization of an intermediate. 32 Variable accessibility and stability of the active domain of RDO to the target DNA due to chromatin structure and nucleases might cause large variations in the RDOmediated gene repair rate, which have been observed in mammalian cells. This large variation made it difficult to use RDO for gene repair in mammalian cells in a reproducible manner. Although ODN promoted a relatively low frequency of tyrosinase gene correction, the experimental variation in frequencies was much lower than RDO, ranging between 2 Â 10 À4 and 1 Â 10
À3
. Therefore, based on these results we conclude that the ODN showed more consistent and reproducible gene correction than RDO. Additionally, relying on the presence of pigmented cells, we succeeded in tyrosinase 3 where ODN showed a similar gene correction frequency as RDO but much more consistent gene correction rate. ODN is easier to synthesize and thus would become more accessible for researchers interested in using this technology.
To our knowledge, this is the first report demonstrating the permanent genotypic and phenotypic changes by ODN in mammalian cells. In this study, we also addressed an important issue but often missing in the most gene repair studies, a conclusive analysis of clones. In addition to our previous paper, 1 there has been only one report 33 that attempted to address such clonal analysis. However, this clonal analysis was carried out with transfected genes without a determination of the DNA copy number, making their results impossible to interpret. Thus, our previous 1 and current studies remain as the only examples of clonal analysis in mammalian cells.
Because of low frequency of gene alteration, we have considered a possibility of spontaneous reversion of the missense albino mutation in the tyrosinase. In the earlier work of Bennett and Jackson, 10 the spontaneous correction of albino tyrosinase was observed in Melan-C cells. However, it is important to note that the spontaneous reversion of this mutation has been detected only at very early passages of the primary cultured melanoblasts during the establishment of Melan-C cells. Moreover, all spontaneous revertants lost pigmentation with passages and did not survive the freezing and thawing cycles. 10 In all targeting experiments, we have used Melan-C cells after the 18th passage and we have never detected any spontaneous reversion of cultured albino melanocytes treated with the control oligonucleotides, RDO or ODN, which contained no mismatch to the targeted base. Furthermore, we have not detected any other mutation in the c-Kit gene in all clones other than the targeted activating mutation. In fact, two new melanocyte cell lines with the c-kit mutation have been generated in this study. These results argue against the possibility that clones arose from spontaneous reversion, mutation or cross-contamination of existing cell lines.
In this study, we showed that it is possible to alter two endogenous genes, the tyrosinase in chromosome 7 and the c-kit in chromosome 5, in a biologically relevant system with a functional and phenotypic change. For the tyrosinase, we determined phenotypic and functional changes by pigmentation and enzymatic activity. For the c-kit, functional change was shown by auto-phosphorylation and enhanced kinase activity of the Kit receptor in melanocytes. It is known that activation of the Kit receptor in hematopoietic cells could result in transformation and tumor progression. 20 In contrast, none of these activating mutations has ever been found in melanomas, where downregulation of the Kit receptor transcription is usually associated with the tumor development. The cell lines that have been generated by gene targeting in this study may serve as models for understanding of the biological activities and the tumorigenic potential of the Kit receptor in melanocytes.
Characterization of the biological consequences of the activated Kit in targeted melanocytes will continue and be published elsewhere.
Finally, we demonstrate that if two oligonucleotides are present within the nucleus of a 'repair-competent' cell, then dual targeting events can occur with a relatively high frequency. If the gene alteration of tyrosinase and c-kit occurs independently, then we expect that c-kit would be mutated in one out of 1000-5000 tyrosinase corrected, pigmented cells. In contrast, two out of eight isolated pigmented clones harbored the mutated c-kit gene. Comparison of frequencies of single, double and multiple targeting events in melanocytes and other cell systems will continue to be of great interest and will require further investigation currently ongoing in our laboratory. The possibility of simultaneous targeting indicates that enrichment of targeted cells with the desired gene alteration could be achieved by selection of the cells according to the change in their phenotypic marker, in our case a pigmentation change due to correction of the albino tyrosinase. Such approaches may help to overcome low frequency of gene correction, a limitation of the current oligonucleotide-based strategies of gene targeting and may be used to generate novel cell lines for functional genomics and stem cell research.
Materials and methods

Synthesis and purification of oligonucleotides
Single-stranded oligonucleotides were synthesized in a 1 mmol scale by ABI 392 DNA/RNA synthesizer (Foster City, CA, USA) using a standard phosphoramidite procedure. Chemicals used for synthesis were purchased from Glen Research (Sterling, VA, USA) and Perkin Elmer (Foster City, CA, USA). The crude oligonucleotides were purified by the procedure described previously. Transfection. The liposome-oligonucleotide complexes were added to the cells containing 0.8 ml of growth media (Superfect) or 0.5 ml OptiMEM (DMRIE-C). Cells were washed with PBS 3 h (Superfect) or 8 h (DMRIE-C) after transfection and fed with a fresh growth media with PMA.
Cells were monitored for a change in pigmentation over a week by microscopy. Initially, 10-20 cloning cylinders were placed on the areas containing each pigmented clones. Collected cells from a cloning cylinder Oligonucleotide-based dual gene targetting V Alexeev et al contained both pigmented and unpigmented cells. These cells were further plated at clonal density and 5-7 rounds of subcloning procedures were performed to isolate individual black-pigmented clones.
For the determination of the Kit tyrosine kinase activity, melanocytes were seeded onto the 100 mm culture dishes at an initial density of 5 Â 10 5 cells per dish and allowed to grow until 80% of confluency. Then, normal culture media was changed to the RPMI 1640 media containing 0.5% BSA for 3 days. For the liganddependant Kit receptor activation, SCF was diluted in the RPMI 1640 media, containing 0.5% BSA to a final concentration of 100 Zg/ml. Melanocytes were incubated with the SCF-containing media for 15 min at 371C and washed 3 times with ice-cold PBS and lysed for protein analysis as described below.
Detection of gene alteration by RFLP analysis and DNA sequencing
For tyrosinase, the genomic DNA was isolated from pigmented clones and subjected to PCR amplification generating a 354 bp fragment using the primers, 5
0 -AAGAATGCTGCCCACCATG-3 0 and 5 0 -GACATA-GACTGAGCTGATAGTATGTT-3 0 . The PCR products were digested with Dde I restriction enzyme (NEB, Beverly, MA, USA) and reaction products were analyzed by a 15% polyacrylamide gel (PAGE). To detect the c-kit gene alteration, the same genomic DNA was amplified by PCR reaction using primers, 5
0 -GCTGAGCTTCTCC-TACCAGG-3 0 and 5 0 -GGATTTTCCTCTGGGAGCTC -3 0 , which generated a 280 bp fragment. For sequencing analysis, the PCR product was column-purified (Qiagen, Valencia, CA, USA) and subjected to the automatic DNA sequencing (ABI373A, Applied Biosystems, Foster City, CA, USA) with a direct or a reverse primer.
Western blot analysis
For Western blot analysis of the autophosphorylation of the Kit receptor, 1 Â 10 6 cells from each pigmented clone were serum-starved for 3 days and were either treated or not with SCF for 15 min. Cells were lysed in a buffer, containing 1% NP-40, 50 mM Tris-HCl pH 8.5, 150 mM NaCl, 5 mM EDTA, 1 mM Na 3 VO 4 , 50 mM NaF, 2.5 mM pnitro-phenyl phosphate, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin. The Kit receptor was immunoprecipitated by anti-c-Kit monoclonal antibodies ACK 45 (BD PharMigen, San Diego, CA, USA) for 3 h at +41C. Immunocomplexes were captured by Protein G Sepharose (Pharmacia, Piscataway, NJ, USA) and washed 3 times with the lysis buffer. Proteins were resolved on a 7% SDS-PAGE and transferred to a nitrocellulose membrane (Millipore, Bedford, MA, USA). Tyrosine phosphorylation of the Kit receptor has been detected with anti-phosphotyrosine antibodies PY-20 (BD Transduction Laboratories, Lexington, KY, USA). The antiphosphotyrosine antibodies were removed from the nitrocellulose membrane by treatment with a stripping buffer (100 mM 2-mercaptoethanol, 2% sodium dodecyl sulfate, 62.5 mM Tris-HCl pH 6.7) (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Then, the Kit receptor was detected by the anti-c-Kit polyclonal antibodies sc-168 (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
In vitro kinase assay
The c-kit altered and c-kit normal pigmented clones were serum-starved for 3 days and lysed as described above. Duplicated plates of the same clones were treated with SCF prior to lysis. Kit receptor has been immunoprecipitated and immunocomplexes were washed once with PBS, 2 times with the lithium buffer (0.5 M LiCl, 50 mM Tris-HCl pH 7.4), once with the kinase buffer (10 mM MnCl 2 , 20 mM Tris-HCl pH 7.4) and resuspended in 20 ml of the kinase buffer containing 10 mCi [g- 32 P] ATP per reaction. All procedures were carried out at +41C. Following incubation for 10 min at 301C, an equal volume of 2 Â SDS sample buffer was added, and samples were subjected to a 7% SDS-PAGE. After electrophoresis, the gel was fixed with 7% acetic acid, 40% methanol, dried and autoradiographed.
